113 healthtech investors in London
We list 113 healthtech investors in London as of November 2026: 2 have an SEC filing on file and 111 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026.
Top 5 healthtech investors in London, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Bullhound Capital
Type: VC firm · HQ: London, United Kingdom · Stages: Growth · Focus: Healthtech, AI, Quantum, Robotics · Latest activity: New deal, Oct 2026 · Fund size or assets: €1.0B (own site)
Dated new deal in Oct 2026; €1.0B on file (own site); states healthtech and digital health as a focus; names the UK as where it invests; 8 named decision-makers on file.
Parkwalk Advisors
Type: SEIS/EIS fund · HQ: London, United Kingdom · Stages: Seed, Series A, Series B, Growth · Focus: Healthtech, AI, Industrial Tech, Energy · Latest activity: New fund, Sep 2026 · Fund size or assets: £500M (own site)
Latest fund filing dated Sep 2026; £500M on file (own site); states healthtech and digital health as a focus; names the UK as where it invests; 8 named decision-makers on file.
MS+PARTNERS
Type: Fund manager · HQ: London, United Kingdom · Stages: Growth · Focus: Healthtech, Industrial Tech, Energy, Climate Tech · Latest activity: New fund, Sep 2026 · Fund size or assets: €300M (own site)
Latest fund filing dated Sep 2026; €300M on file (own site); states healthtech and digital health as a focus; names the UK as where it invests; 6 named decision-makers on file.
Gresham House Ventures
Type: VC firm · HQ: London, United Kingdom · Stages: Series A, Growth · Focus: Healthtech, AI, Marketing Tech, Fintech · Latest activity: New deal, Sep 2026 · Fund size or assets: £200M (own site)
Dated new deal in Sep 2026; £200M on file (own site); states healthtech and digital health as a focus; names the UK as where it invests; 8 named decision-makers on file.
IW Capital
Type: SEIS/EIS fund · HQ: London, United Kingdom · Stages: Series A · Focus: Healthtech, AI, SaaS, Fintech · Latest activity: New deal, Oct 2026 · Fund size or assets: £185M (own site)
Dated new deal in Oct 2026; £185M on file (own site); states healthtech and digital health as a focus; names the UK as where it invests; 8 named decision-makers on file.
First 25 of 113 healthtech investors in London
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Bullhound Capital | VC firm | London, United Kingdom | Growth | Healthtech, AI, Quantum, Robotics | New deal, Oct 2026 | €1.0B (own site) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Energy | New fund, Sep 2026 | £500M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| MS+PARTNERS | Fund manager | London, United Kingdom | Growth | Healthtech, Industrial Tech, Energy, Climate Tech | New fund, Sep 2026 | €300M (own site) | 4 Nov 2026 | 6 names, firm email · Unlock |
| Gresham House Ventures | VC firm | London, United Kingdom | Series A, Growth | Healthtech, AI, Marketing Tech, Fintech | New deal, Sep 2026 | £200M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| IW Capital | SEIS/EIS fund | London, United Kingdom | Series A | Healthtech, AI, SaaS, Fintech | New deal, Oct 2026 | £185M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Pembroke VCT | VC firm | London, United Kingdom | Seed, Series A, Growth | Healthtech, AI, Consumer, SaaS | Portfolio news, Sep 2026 | £235M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Healthtech, Biotech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Bayes Entrepreneurship Fund | Government or university fund | London, United Kingdom | Seed, Series A | Healthtech, AI, Fintech, Developer Tools | New deal, Oct 2026 | £15M (own site) | 4 Nov 2026 | 7 names, firm email · Unlock |
| Salica Investments | Fund manager | London, United Kingdom | Seed, Series A, Growth | Healthtech, Fintech, AI, Climate Tech | Portfolio news, Oct 2026 | £760M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Developer Tools | Portfolio news, Oct 2026 | $5.7B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Highland Europe | VC firm | London, United Kingdom | Growth | Healthtech, AI, Cybersecurity, SaaS | New fund, Jul 2026 | €1.1B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Empirical Ventures | SEIS/EIS fund | London, United Kingdom | Pre-seed, Seed | Healthtech, Biotech, Energy, Semiconductor | New deal, Jul 2026 | £50M (own site) | 4 Nov 2026 | 6 names, firm email · Unlock |
| AVP | VC firm | London, United Kingdom | Series A, Series B, Growth, Late stage | Healthtech, Fintech, SaaS, Insurtech | Portfolio news, Oct 2026 | 4 Nov 2026 | 8 names · Unlock | |
| Bethnal Green Ventures | VC firm | London, United Kingdom | Pre-seed, Seed, Series A | Healthtech, Logistics, Edtech, Impact | New deal, Aug 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| British Design Fund | SEIS/EIS fund | London, United Kingdom | Seed | Healthtech, Climate Tech, Energy, Industrial Tech | Portfolio news, Oct 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| Outward VC | VC firm | London, United Kingdom | Pre-seed, Seed | Healthtech, AI, Fintech, Logistics | New deal, Nov 2026 | 4 Nov 2026 | 6 names · Unlock | |
| Earlybird Venture Capital | VC firm | London, United Kingdom | Pre-seed, Seed, Series A | Healthtech, AI, Developer Tools, Fintech | New deal, Jul 2026 | €2.5B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Valia Ventures | VC firm | London, United Kingdom | Pre-seed, Seed, Series A, Series B, Growth | Healthtech, AI, Generalist, Energy | Portfolio news, Aug 2026 | $50M (SEC Form D, 2022) | 5 Nov 2026 | 3 names · Unlock |
| Cornerstone VC | VC firm | London, United Kingdom | Pre-seed, Seed | Healthtech, AI, Fintech, Logistics | Portfolio news, Oct 2026 | 4 Nov 2026 | 5 names, firm email · Unlock | |
| Pi Labs | VC firm | London, United Kingdom | Pre-seed, Seed, Series A | Healthtech, AI, Proptech, Climate Tech | Portfolio news, Sep 2026 | 5 Nov 2026 | 8 names · Unlock | |
| Sofinnova Partners | VC firm | France (London office) | Seed, Series A, Series B, Growth | Healthtech, Biotech, Fintech, Agritech | New fund, Nov 2025 | €4.0B (own site) | 5 Nov 2026 | 8 names · Unlock |
| Novastar Ventures | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, Climate Tech, Energy, Logistics | New fund, May 2026 | $350M (own site) | 5 Nov 2026 | 8 names, firm email · Unlock |
| White Star Capital | VC firm | London, United Kingdom | Seed, Series A, Series B | Healthtech, AI, Fintech, Crypto and Web3 | New fund, Aug 2026 | $250M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Ascension | VC firm | London, United Kingdom | Pre-seed, Seed | Healthtech, Fintech, Climate Tech, Deep Tech | New deal, May 2026 | £158M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| MMC Ventures | VC firm | London, United Kingdom | Seed, Series A | Healthtech, AI, Fintech, Data | New deal, Nov 2026 | 4 Nov 2026 | 8 names · Unlock |
You are seeing 25 of 113. The full list adds 88 more investors and 666 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 113 break down
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 44 | 39% |
| Seed | 79 | 70% |
| Series A | 54 | 48% |
| Series B | 28 | 25% |
| Growth | 48 | 42% |
Stage is our research. A firm can back more than one stage.
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 74 | 65% |
| SEIS/EIS fund | 8 | 7% |
| Fund manager | 8 | 7% |
| Angel network | 6 | 5% |
| Corporate VC | 5 | 4% |
| Accelerator | 4 | 4% |
Method and limits
- Source
- 2 of the 113 rows carry an SEC filing (Form D or Form ADV). All 113 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio. Place: an office in London.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 113 rows: stage 110, sector 113, fund size 46, website 113. In the paid file: named decision-makers on 103 rows, firm email on 63, LinkedIn page on 85, check size on 58.
- Corrections
- Email hello@theinvestordatabase.com or use the update form. We act within 5 working days.
Questions
How many healthtech investors in London are there?
We list 113 as of November 2026. 46 of the 113 have a fund filing or a dated deal in the last 12 months.
Which healthtech investors in London raised a new fund in the last 12 months?
6 of the 113 have a fund filing dated in the last 12 months. The most recent on this list are Parkwalk Advisors (Sep 2026), MS+PARTNERS (Sep 2026) and White Star Capital (Aug 2026).
How do I contact healthtech investors in London?
The paid file holds 666 named decision-makers across 103 of these 113 and a firm email for 63. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on healthtech investors in London come from?
2 of the 113 rows have an SEC filing on file (Form D or Form ADV) and 111 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Related lists
AI investors in London (142)SaaS investors in London (141)Fintech investors in London (113)Climate tech investors in London (71)Consumer investors in London (67)Deep tech investors in London (66)B2B investors in London (49)Biotech investors in London (42)Medtech investors in London (36)Energy investors in London (36)Media investors in London (34)Cybersecurity investors in London (28)Future of work investors in London (24)Industrial tech investors in London (22)Hardware investors in London (20)Mobility investors in London (19)Edtech investors in London (18)Developer tools investors in London (16)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to healthtech and digital health and the UK. Guide: how to find investors for a healthtech and digital health startup. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.